Balachandran Madhavan 4

What Happened

• Balachandran Madhavan, a director of Replimune Group, was granted a derivative award on April 1, 2026 for rights to 44,500 shares. The reported acquisition price is $0.00, so no cash was paid at grant and the reported immediate value is $0. The filing classifies the transaction as a derivative award (code A).

Key Details

• Transaction date: 2026-04-01
• Instrument/amount: 44,500 derivative shares granted @ $0.00 (acquired)
• Vesting: The shares underlying this award vest entirely on 2027-04-01 (footnote F1)
• Shares owned after transaction: Not specified in this Form 4
• Filing timeliness: This Form 4 was filed late due to an “inadvertent administrative error” (the filing notes a late report)

Context

• This was a grant/award of a derivative security (rights/options to acquire shares) rather than an open-market purchase or sale; no shares were sold or bought on the market at the time of the grant. The award vests in one year, so any future acquisition or sale would likely occur after vesting or exercise. The late filing is disclosed in the Form 4; investors should note timing but not infer intent from the delay.